Find Out Where You Are Most At Risk For Catching A Virus This Easter.

#COVID19 #SARSCoV2 #Pandemic #CovidIsNotOver #CovidIsAirborne #H5N1 #Measles #WhoopingCough #RSV #Norovirus #Tuberculosis #Polio #Mpox #MaskUp #N95 #KeepMasksInHealthcare

www.youtube.com/watch?v=27d7...

This is #PublicHealth messaging

We used to have this in #Victoria #Australia

😮‍💨

#DutyOfCare

#CovidIsNotOver
#CleanAir #Ventilation
#LongCovid #LongCovidKids

#CovidIsNotOver ❗️

4/.
7-Tage-Fallzahl über alle AG: 250 (277)
7-Tage-Inzidenz über alle AG: 0,3 (0,3)

Mit durchschnittlicher Dunkelziffer von *MAL* 60 noch dazu !! 🔥

#CovidIsNotOver #DurchseuchungStoppen #DieMaskeBleibtAuf #DurchseuchungOhneUns

Sehr klar MASSIVE Untererfassung in allen AGs !!

Journal of Infection and Public Health: Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance ABSTRACT Background The impact of SARS-CoV-2 on epigenetic regulation in people with HIV (PWHIV) is not well understood. MicroRNAs, key post-transcriptional regulators, may serve as biomarkers of disease. This study aimed to identify plasma miRNAs ref...

Journal of Infection and Public Health: Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance #ThatCovidLife #CovidIsNotOver

Weiterhin gilt (auch mit Blick auf die hohe Zahl LongCovid-Fälle) #CovidIsNotOver - aber viele wollen das ja *nicht* wahrhaben ... oder meinten gar, #COVID19 nach Einstellung fast aller Testungen 2023 per Order für "beendet" erklären zu können. 🤔🤦‍♀️

#KinderdurchseuchungStoppen @suse1603.bsky.social

2/.
Bitte beachten, daß der aktuelle Dunkelzifferfaktor real bei durchschnittlich MAL 60 liegt (laut Abwasser, ITS)! 🤔

Je nach AG werden die DZ-Werte zwischen DZF ~32 (in AG 80+) bis ~1.026 (in AG 05-14) geschätzt! 😱 (kalibriert an SentiSurv)

#CovidIsNotOver #DurchseuchungStoppen #TeamVernunft

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles FDA's stricter trial requirements and low U.S. vaccine uptake hinder study progress Pfizer and BioNTech cite slow enrollment, not safety concerns, for stopping trial Moderna's study faces similar struggles, sources say LONDON, April 1 (Reuters) - Vaccine makers Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab halted a large U.S. trial of their updated COVID-19 ​vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too low to generate the needed data. In a letter to trial ‌investigators dated March 30, seen by Reuters and previously unreported, Pfizer said it would stop surveillance for signs of COVID illness for all participants in the study after April 3. Enrollment was closed on March 6, following a review of current epidemiological trends, it said. The move comes as COVID vaccine makers grapple with pushback from the U.S. administration and weak U.S. demand for the shots. The U.S. Food and Drug Administration toughened requirements for COVID ​vaccine use last year, including asking for large, placebo-controlled trials in the 50-64 age group for it to be included in recommendations. Pfizer and BioNTech told Reuters they ​had informed the FDA about their intent to halt the COVID-19 vaccine study, citing challenges getting enough participants. The target enrollment was roughly ⁠25,000 to 30,000 participants. "This study is not ending as a result of any safety or benefit-risk concerns. We intend to stop the study due to slow enrollment and therefore the inability ​to generate relevant post-marketing data," the companies said. Shares of Pfizer and rival COVID-vaccine maker Moderna (MRNA.O), opens new tab were up nearly 1%, while U.S.-listed shares of BioNTech rose about 2%. FDA vaccine chief Vinay Prasad, ​who had pushed for the placebo-controlled trials in healthy adults and children, is leaving the agency this month. Experts warned that requiring large new trials could delay or limit the availability of updated shots for lower-risk groups. It was unclear what the path to approval could be for this group. The FDA was not immediately available for comment. The companies did not comment on plans for marketing the shot for this age ​group. The Pfizer-BioNTech study halt comes ahead of an expected May meeting of the FDA's Vaccines and Related Biological Products Advisory Committee, which would use study data to guide decisions on strain ​selection for COVID vaccines this autumn. "Without the data, there probably just won't be a presentation," said Dr. Jesse Goodman, a former FDA chief scientist. "And without the presentation, there may not be a specific approval ‌for this ⁠age group." Two sources from companies that manage 18 of the 208 trial sites, said Pfizer told them in writing in early March to stop recruitment. The trial aimed to test the efficacy, immune response and safety of an updated COVID vaccine from Pfizer and BioNTech in healthy adults aged 50 to 64. The FDA required participants have no chronic conditions such as hypertension or diabetes. "This is a very difficult population to recruit," said one executive at a contract research organization involved in the trial, who spoke on the condition of anonymity. "Even when ​patients are willing to participate in COVID ​studies, more than 80% fail at pre-screening ⁠because they don't meet the health criteria. It's been a real challenge to enroll enough patients, particularly given the scale of these trials," the executive said. Currently, no COVID-19 vaccines have full FDA approval for healthy adults aged 50 to 64. Pfizer and ​BioNTech's Comirnaty and Moderna's Spikevax and next-generation mNEXSPIKE are approved for adults aged 65 and older, as well as for younger people ​who are at higher ⁠risk of severe COVID-19. Moderna is running a similar U.S. study with an aim to enroll 30,000 volunteers, and is also facing recruitment challenges, sources at four sites said. That study is expected to be completed in June 2027. Moderna did not immediately respond to a Reuters request for comment. COVID vaccines remain significant products for their makers, though demand has fallen sharply from pandemic peaks. Only about 18% ⁠of Americans received ​a COVID booster during the 2025–26 season, according to data from the U.S. Centers for Disease Control and ​Prevention, even as the virus continues to cause tens of thousands of deaths each year, including an estimated 8,000 to 12,000 among adults aged 50 to 64. Updated COVID vaccines for approved groups are typically cleared based on immune ​response data showing how well a new formulation generated antibodies against circulating variants, similar to the agency's approach for annual flu shots. Bhanvi is a London-based reporter covering European pharmaceutical companies and the healthcare industry. She previously covered U.S. health and pharma firms, with a focus on the new weight loss drugs that are transforming the obesity treatment space. Her coverage includes a trend piece on the underuse of their weight-loss drugs among men, increased interest in therapies being developed for preservation of lean mass, and a scoop on gene therapy maker Sarepta defying an FDA order to stop shipping its muscular dystrophy treatment.

Reuters: Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles #ThatCovidLife #CovidIsNotOver

En plus de notre énorme stock de masques Savoy Médical, on a désormais aussi accès à un énorme stock de Texinov via l'ARRA !

bsky.app/profile/asso...

C'est la danse des becs de canard 🦆

#AutoDéfenseSanitaire
#CovidIsNotOver
#MaskUp
#CovidIsAirborne

Israel is systematically killing health workers in Lebanon From bombed ambulances to rescuers killed mid-mission, testimonies and data reveal how frontline medics in Lebanon are being caught and targeted by Israel.

This is how Israel is systematically killing health workers under the cover of war in Lebanon #ThatCovidLife #CovidIsNotOver

BMJ Global Health: Safeguarding healthcare workers in Gaza and throughout occupied Palestine International humanitarian law stipulates specific obligations during armed conflict, including the protection of healthcare and humanitarian workers. There has been a recent increase in attacks on humanitarian workers in places affected by armed confl...

BMJ Global Health: Safeguarding healthcare workers in Gaza and throughout occupied Palestine #ThatCovidLife #CovidIsNotOver

Aus der Reihe "Experten haben herausgefunden..." 🔥

#CovidIsNotOver #MaskUp
#LongCovid

eClinicalMedicine: Long COVID and risk of incident cardiovascular disease: a prospective cohort study using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohort Background Long COVID has emerged as a global health challenge, with increasing evidence of cardiovascular sequelae. Most previous studies have focused on hospitalised cohorts, whereas cardiovascular risk in community-managed long COVID cases remains l...

eClinicalMedicine: Long COVID and risk of incident cardiovascular disease: a prospective cohort study using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohort #ThatCovidLife #CovidIsNotOver

Module 3: The impact of the Covid-19 pandemic on the healthcare systems of the United Kingdom - UK Covid-19 Inquiry The independent public inquiry to examine the Covid-19 pandemic in the UK

Today I #AmReading module 3 of the #Covid19 public inquiry, and looking forward to the bits where they acknowledge WE SHOULD HAVE BEEN WEARING MASKS ALL ALONG

#WearAMask #CovidIsNotOver

covid19.public-inquiry.uk/reports/modu...

'Today is March 2224, 2020.' (bold sans-serif text at center) (bottom small circle with line thru it and inverse colored letters for covid action network): c A n.

#CovidIsNotOver #SARSCoV2 https://covid.aktion.network

Frankreich 🇨🇵

„Sehr besorgniserregender“ Anstieg bei Krankmeldungen.

Ich tippe mal, der Grund für den Anstieg liegt in der permanenten Durchseuchung mit einem hochpathogenen Virus. 🤔

Aber hey, was weiß ich schon.

#CovidIsNotOver #MaskUp

Si la crise du Covid-19 a pu installer une forme de défiance, elle a aussi joué un rôle d’accélérateur majeur de la diffusion des connaissances sur la vaccination auprès du grand public. Les termes d’immunité collective, de couverture vaccinale, de circulation du virus, de bénéfices / risques etc. font désormais partie du vocabulaire courant des Français. C’est aussi sur cette nouvelle culture vaccinale que nous souhaitons renforcer la confiance via le déploiement de cette stratégie et ses actions d’information et de sensibilisation à la vaccination.

``` AXE 2 UN PARCOURS VACCINAL SIMPLIFIÉ ENRICHI Après l’extension des compétences vaccinales des professionnels de santé non-médecin qui permet d’élargir l’offre de vaccination, cet axe vise à multiplier l’offre vaccinale en milieu libéral, à l’hôpital ou à l’école. Il s’attache, également, à améliorer l’offre vaccinale saisonnière, en particulier pour la campagne contre la grippe et le COVID-19. Par ailleurs, il intègre des actions ciblées « d’aller- vers » et de « ramener vers » pour atteindre les populations les plus précaires ou éloignées du soin afin garantir une protection équitable pour tous. AXE 3 UNE POLITIQUE VACCINALE PLUS EFFICIENTE Cet axe prend en compte le virage numérique en santé et s’appuie sur les nouveaux outils pour améliorer l’adhésion à la vaccination et le rattrapage vaccinal. Il intégrera également une dimension médico-économique dans la décision vaccinale pour optimiser l’utilisation des ressources disponibles et ainsi maximiser les bénéfices en matière de santé publique. AXE 4 FORMER LES PROFESSIONNELS DU SECTEUR SANITAIRE À LA PROMOTION DE LA VACCINATION ET ACTUALISER LE CALENDRIER VACCINAL DE CES PROFESSIONNELS Cet axe vise à sensibiliser et mieux former les professionnels de santé pour répondre aux interrogations et aux hésitations de leurs patients vis-à-vis de la vaccination. Il intégrera également une actualisation du calendrier vaccinal de ces professionnels en fonction de l’épidémiologie et de contraintes réglementaires. AXE 5 RENFORCER LA PROMOTION DE LA VACCINATION (INFORMATION ET COMMUNICATION) Cet axe vise à favoriser l’adhésion vaccinale et faire face à la réticence vaccinale en général et en particulier celle des personnes âgées de 65 ans et plus (grippe saisonnière, COVID-19). ```

Une offre vaccinale plus lisible Action 2.6 Sanctuariser les dates de la campagne de vaccination contre la grippe saisonnière, réduire la durée de celle-ci et envoyer les bons d’invitation plus tardivement afin de maintenir l’attention de la population et l’implication des acteurs locaux tout au long de celle-ci Action 2.7 Aligner progressivement les dates et les critères d’éligibilité de la vaccination contre la COVID-19 avec ceux de la campagne de vaccination contre la grippe saisonnière

RENFORCER LA PROMOTION DE LA VACCINATION (INFORMATION ET COMMUNICATION) Objectif : Mener une communication scientifique, objective et transparente pour favoriser l’adhésion de la population, en particulier celle des personnes âgées vis-à-vis de la prévention des infections respiratoires aiguës Action 5.1 Renforcer l’adhésion à la vaccination des Français au moyen de campagnes d’information et de sensibilisation éducative (efficacité, risques évités, bénéfice / risque) favorisant la lutte contre la désinformation. Action 5.2 Assurer une veille informationnelle continue pour contrer rapidement les fausses informations, notamment sur les réseaux sociaux, et y apporter une réponse vérifiée scientifiquement et coordonnée. Action 5.3 Renforcer / Intensifier la promotion de la vaccination notamment contre les infections respiratoires aiguës (grippe, Covid-19, pneumoccoque, VRS) à destination des personnes de 65 ans et plus en s’appuyant sur des ambassadeurs appartenant à la communauté.

J’ai comme l’impression que tous ceux qui ne veulent pas attraper le #CovidIsNotOver en boucle se sont bien fait avoir par la nouvelle doctrine vaccinale.

cc @winslowsp.bsky.social @associationarra.bsky.social

Covid = Brain damage.

It was never brain "fog."

#CovidIsNotOver

The smartest people I know
wear masks.

#Covid #CovidIsNotOver #Health #Healthcare #Notmild #NotACold
#medsky

Tracking A Major Virus Exposure Point And New 2 Week Covid Death Data!

#COVID19 #SARSCoV2 #Pandemic #CovidIsNotOver #CovidIsAirborne #H5N1 #Measles #WhoopingCough #RSV #Norovirus #Tuberculosis #Polio #Mpox #MaskUp #N95 #KeepMasksInHealthcare

www.youtube.com/watch?v=-UnZ...

Queering Dance Festival presents FROLIC! (Bay Area) Queering Dance Festival presents FROLIC! on April 2-4th, 2026, at Dance Mission Theater in San Francisco, California, presenting six Bay Area LBGTQ+ artists. 2026 Artists Micah Sallid Wailana Simcock Tajinder Virdee B Dean / BODYSTORM Nina Haft & Compa...

Queering Dance Festival presents FROLIC! (Bay Area) #ThatCovidLife #CovidIsNotOver

Clinical Ophthalmology: General Ophthalmology Ocular Symptoms in Long COVID: A Cross-Sectional Study ABSTRACT Introduction: This study compared demographics, socioeconomic characteristics, pre-pandemic health conditions, newly diagnosed health conditions, and long COVID symptoms between participants with and without self-reported new-onset ocular symp...

Clinical Ophthalmology: General Ophthalmology Ocular Symptoms in Long COVID: A Cross-Sectional Study #ThatCovidLife #CovidIsNotOver

'25-'26 #CovidIsNotOver 💉s are formulated to protect against strains from JN.1 lineage of SARS2, the most common variants in USA since Jan '24.

However, BA.3.2 is almost a complete stranger to residents of the U.S.

1/

Yep. #CovidIsNotOver

Die Altersgruppen 05 bis 79 illustrieren somit (leider schon seit längerem!) amtlich den gesellschaftlichen Komplett-AUSFALL - zumindest gegenüber allen Vulnerablen ... 😷 😳

... und die Verleugnungs-Haltung in diesen Altersgruppen ist zutiefst beschämend! 🤦‍♀️ 🤬 🤮

#CovidIsNotOver #MaskUp

Die Abbildung zeigt auf sechs Karten die vom RKI gemeldete Corona 7-Tages-Inzidenz je Landkreis bundesweit für sechs verschiedene Altersgruppen in verschiedenen Farben. ACHTUNG: seit Anfang März 2023 massive Untererfassung! (Wohl weniger als jede 60ste Infektion wird aktuell überhaupt noch amtlich registriert!) ⏩ Somit zeigen die Karten vor allem (besonders im Vergleich mit der *tatsächlichen* Verteilungskurve über alle Altersgruppen und Geschlechter), wie massiv das Ignorieren und Verdrängen inzwischen verbreitet ist !! Die REALE Verteilung über alle Altersgruppen dürfte noch immer einer 'Glockenform' ähneln, wie sie sich aus den Daten von ~zweieinhalb Jahren Infektionen zeigte (siehe die nächste Grafik im weiteren dieses Threads), als noch einigermaßen flächendeckend über alle Altersgruppen getestet wurde! (Die 'amtliche' Zahlenbasis für alle Altersgruppen zwischen 5 bis 79 Jahren ist mittlerweile nahezu ein *TotalAUSFALL* !! Und die Verleugnungs-Haltung in diesen Altersgruppen ist zutiefst beschämend. Denn mindestens diejenigen, die vulnerabel sind - und daher Infektionen mit diesem Virus vermeiden müssen - sind auf solche Informationen zur Vorbeugung dringend angewiesen !!) Für eine Abschätzung der realen Inzidenz-Höhe müssen die Zahlen auch noch mit einem Dunkelziffer-Faktor von aktuell im ø MAL ~60 *multipliziert* werden !!

Corona 7-Tages-Inzidenz pro Altersklasse (zum 2026-04-01)
Beachte: reale Inzidenz aktuell ~23‼️

Alle Credits gehen an Sebastian Mohr (von der tollen ViolaPriesemann Gruppe). Vielen Dank für Ihre Arbeit! ❤️👏

@ralfwittenbrink.bsky.social @dpaessler.bsky.social #CovidIsNotOver #MaskUp #COVIDisAirborne

Please wear a mask in public spaces to protect us from a virus that could 💀 us or cause further disability

🧵 2/2

#COVIDisNotOver #COVIDisntOver

#MasksSaveLives #MasksWork

#MyDisabledLifeIsWorthy

4/.
7-Tage-Fallzahl über alle AG: 277 (214)
7-Tage-Inzidenz über alle AG: 0,3 (0,3)

Mit durchschnittlicher Dunkelziffer von *MAL* 60 noch dazu !! 🔥

#CovidIsNotOver #DurchseuchungStoppen #DieMaskeBleibtAuf #DurchseuchungOhneUns

Sehr klar MASSIVE Untererfassung in allen AGs !!

Environmental Health Perspectives: Associations of Cognitive Function Scores with Carbon Dioxide, Ventilation, and Volatile Organic Compound Exposures in Office Workers: A Controlled Exposure Study of Green and Conventional Office Environments ABSTRACT Background: The indoor built environment plays a critical role in our overall well-being, both due to the amount of time we spend indoors (~90%) and the ability of buildings to positively or negatively influence our health. The advent of susta...

Environmental Health Perspectives: Associations of Cognitive Function Scores with Carbon Dioxide, Ventilation, and Volatile Organic Compound Exposures in Office Workers: A Controlled Exposure Study of Green and Conventional Office Environments #ThatCovidLife #CovidIsNotOver

Weiterhin gilt (auch mit Blick auf die hohe Zahl LongCovid-Fälle) #CovidIsNotOver - aber viele wollen das ja *nicht* wahrhaben ... oder meinten gar, #COVID19 nach Einstellung fast aller Testungen 2023 per Order für "beendet" erklären zu können. 🤔🤦‍♀️

#KinderdurchseuchungStoppen @suse1603.bsky.social